Shwetha Rupendu

Shwetha Rupendu practices at Tennova North Knoxville Medical Center in Powell, Tennessee, part of Tennova Healthcare.

Shwetha Rupendu's NPI, 1467004366, was assigned on July 10, 2019. Shwetha Rupendu holds Massachusetts license 280186.

Shwetha Rupendu's primary practice is Tennova North Knoxville Medical Center, at 7565 Dannaher Way Powell, Powell, TN 37849 in Knox County. The practice phone is (865) 545-8000.

Shwetha Rupendu's primary practice is Tennova North Knoxville Medical Center in Powell, Tennessee, part of Tennova Healthcare. Shwetha Rupendu is also affiliated with Nash General Hospital. The medical group on file is Southeastern Physician Services PC. Dmand AI also links Shwetha Rupendu to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Shwetha Rupendu practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Shwetha Rupendu's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Shwetha Rupendu is licensed in Massachusetts.

CMS data shows 753 Medicare services from Shwetha Rupendu across 5 procedure codes in 2024, for 257 Medicare patients. Medicare paid $65,450 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 257 Medicare patients who saw Shwetha Rupendu in 2024. The largest group is 65 to 74, with 98 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Shwetha Rupendu's median patient age at 70, with 55% women.

In 2024, Shwetha Rupendu wrote 496 Medicare Part D claims for 217 patients. 90% of them were for generic drugs. CMS names the drug for 243 of them, across 12 drugs with 11 or more claims each, at $1,107 in total drug cost. In 2023, CMS named 136 claims across 7 drugs.

Shwetha Rupendu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 85 general payments to Shwetha Rupendu from 23 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $737.